Literature DB >> 20412998

The United Kingdom Joint Committee on Vaccination and Immunisation.

Andrew J Hall1.   

Abstract

The United Kingdom Joint Committee on Vaccination and Immunisation provides advice to the Ministers of Health on all aspects of vaccination. Under recent legislation a recommendation from the Committee confers the right to the vaccine concerned to the population of England Wales. A critical aspect of both advice and recommendations is that the vaccination is shown to reach a cost-effectiveness threshold. This usually requires sophisticated mathematical modelling and economics.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh：

Year:  2010        PMID： 20412998     DOI： 10.1016/j.vaccine.2010.02.034

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  9 in total

1.  Counting the cost of meningococcal disease : scenarios of severe meningitis and septicemia.

Authors:  Claire Wright; Rebecca Wordsworth; Linda Glennie
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

2.  Explaining variation in the uptake of HPV vaccination in England.

Authors:  Varun M Kumar; David K Whynes
Journal:  BMC Public Health       Date:  2011-03-22       Impact factor: 3.295

3.  An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices.

Authors:  Hee Yeon Cho
Journal:  Korean J Pediatr       Date:  2012-01-31

4.  Community-based interventions to improve HPV vaccination coverage among 13- to 15-year-old females: measures implemented by local governments in Japan.

Authors:  Hiroyuki Fujiwara; Yuji Takei; Yoshiki Ishikawa; Yasushi Saga; Shizuo Machida; Akiyo Taneichi; Mitsuaki Suzuki
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

5.  Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Authors:  Bernhard Ultsch; Oliver Damm; Philippe Beutels; Joke Bilcke; Bernd Brüggenjürgen; Andreas Gerber-Grote; Wolfgang Greiner; Germaine Hanquet; Raymond Hutubessy; Mark Jit; Mirjam Knol; Rüdiger von Kries; Alexander Kuhlmann; Daniel Levy-Bruhl; Matthias Perleth; Maarten Postma; Heini Salo; Uwe Siebert; Jürgen Wasem; Ole Wichmann
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

Review 6.  Economic evaluation of vaccines in Canada: A systematic review.

Authors:  Ayman Chit; Jason K H Lee; Minsup Shim; Van Hai Nguyen; Paul Grootendorst; Jianhong Wu; Robert Van Exan; Joanne M Langley
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

7.  What kind of 'a girls' thing'? Frictions and continuities in the framing and taming of the HPV vaccine in Finland.

Authors:  Mikko J Virtanen
Journal:  Sociol Health Illn       Date:  2019-04-03

Review 8.  SMART Vaccines 2.0 decision-support platform: a tool to facilitate and promote priority setting for sustainable vaccination in resource-limited settings.

Authors:  Benjamin J J McCormick; Peter Waiswa; Celia Nalwadda; Nelson K Sewankambo; Stacey L Knobler
Journal:  BMJ Glob Health       Date:  2020-11

9.  MIDCAN: A multiple input deep convolutional attention network for Covid-19 diagnosis based on chest CT and chest X-ray.

Authors:  Yu-Dong Zhang; Zheng Zhang; Xin Zhang; Shui-Hua Wang
Journal:  Pattern Recognit Lett       Date:  2021-07-14       Impact factor: 3.756
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.